Insulin materials

Therapeutics. Therapeutic materials represent a class of polypeptides that are a low volume, high value product. The production system need not be very efficient but the quaHty of the recombinant protein has to be extremely pure (33,34). Thus high cost mammalian production systems can be tolerated. However, some of the therapeutic proteins such as insulin, human growth hormone, interleukins, interferon, and streptokinase are produced microbially. 

In terms of membrane area used and doUar value of the membrane produced, artificial kidneys are the single largest appHcation of membranes. Similar hoUow-fiber devices are being explored for other medical uses, including an artificial pancreas, in which islets of Langerhans supply insulin to diabetic patients, or an artificial Uver, in which adsorbent materials remove bUinibin and other toxins. 

Hepoxylins are metabolites of arachidonic acid which arise from 12-HPETE in tissues such as pancreatic islet cells (where they stimulate glucose-dependent insulin release) and brain (where they appear to have a neuromodulatory role). The structure of the hepoxylins was confirmed by synthesis which also has provided this scarce material for biological investigation. 

When the capsule reaches the ileo-cecal junction, the native bacteria cause rupture of the azo crosslink, allowing dissolution of the polymer and capsule material, releasing the insulin. 

Human serum albumin (HSA) may be used as a protectant against adsorptive loss of proteins present at low concentrations. HSA is present at higher concentration than the active substance and is preferentially adsorbed, coating the surface of interest and preventing adsorption of the drug. For example, insulin is subject to adsorptive loss to hydrophobic materials. Addition of 0.1-1.0% HSA has been reported to prevent this adsorptive loss [9],... 

Insulin aggregation and precipitation was an impediment to the development of implantable devices for insulin delivery as noted by several investigators working with conventional insulin infusion devices [51-54]. The potential causes of the observed aggregation and precipitation are thermal effects, mechanical stress, the nature of the materials in contact with the insulin solution, formulation factors, and the purity of the insulin preparation. 

The starting material loaded onto the column is fairly pure (—92 per cent), and this step yields a final product of approximately 99 per cent purity. Over 95 per cent of the insulin activity loaded onto the column can be recovered. A single column run takes in the order of 1 h. 

In another qualitative study, EDX analysis was used to study the nature of the precipitate occasionally formed in Zn-insulin solutions [73]. Identification of the EDX peaks obtained for the crystalline precipitates enabled the deduction that the solid consisted of a Zn-insulin complex, and a rough analysis of the peak intensities indicated that the composition of the precipitate was comparable to that existing in the starting materials. The combination of the EDX technique with scanning electron microscopy enabled the analyses to be conducted on relatively few numbers of extremely small particles. 

The toxicologist should be prepared to do nothing if the material is well-known, its properties are understood, and there is adequate characterization of the nature of the preparation supplied for example, human insulin or growth hormone produced by genetic engineering should not be submitted to prolonged safety tests in animals, provided that the molecular forms present are sufficiently well understood. 

Materials Required Solution (1) Dissolve 10 mg of insulin in 1 ml of the mobile phase Solution (2) Dilute 100 i/ of solution (1) to 10 ml with the mobile phase and Solution (3) Dissolve 10 mg of procine insulin EPCRS of bovine insulin EPCRS, as appropriate, in 1 ml of the mobile phase. 

Figure 3.23 Selectivity of phenyl and alkyl bonded stationary phase materials for protein separation. Column A, TSK gel phenyl-5PW RP, 75 mm x 4.6 mm i.d. B, TSK gel TMS 250, 75 mm x 4.6 mm i.d. eluent, 60 min linear gradient elution from 5% of 0.05% trifluoroacetic acid in 5%> aqueous acetonitrile to 80% of 0.05% trifluoroacetic acid in 80% aqueous acetonitrile flow rate, lml min-1 detection, UV 220 nm. Peaks 1, ribonuclease 2, insulin-, 3, cytochrome c 4, lysozyme-, 5, transferrin-, 6, bovine serum albumin-, 1, myoglobin-, and 8, ovalbumin.

Biotechnology-derived products have led to renewed interest in establishing reference standards based on the same bulk of material. Thus a single formulation, assay, and reference standard may be the fact worldwide. This situation can become complex such as with insulin where both biotechnology-derived insulin and animal-source insulin are in the marketplace at the same time. 

The isolation of the pure material was not the end of the story. Deducing the structure of vitamin B12 was a saga itself. Dorothy Crowfoot Hodgkin, an English scientist, won a Nobel Prize in Chemistry in 1964 in part for getting this structure. This was one of the early triumphs of the technique of X-ray diffraction. She was a amazingly productive structural chemist, getting the structures for cholesterol and insulin as weU. 

An individual caimot import injections that contain substances of human or animal origin (except insulin) without an SAS approval. The TGA considers that these injections represent a high risk from inadequately or improperly prepared materials (including a lack of sterility) and, therefore, approvals will only be granted to the supervising physician. 

---